When was Neurogram founded?

Neurogram was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Neurogram located?

Neurogram is headquartered in Atlanta, United States.

Who is the current CEO of Neurogram?

Daniele De Mari of Neurogram. They have also founded 1 company.

How many employees does Neurogram have?

As of Mar 31, 2026, the latest employee count at Neurogram is 27.

Is Neurogram a funded company?

Neurogram is a funded company, having raised a total of $4.4M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 23, 2023.

When was the latest funding round of Neurogram?

Neurogram's latest funding was a $***** Seed round on Jul 29, 2025, with participation from 1 investor.

Where does Neurogram rank among its competitors?

Neurogram ranks 74th amongst 779 active competitors, of which 170 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was AIdoc, which secured $150M in Apr, 2026.

Who are the top competitors of Neurogram?

Neurogram's top competitors include AIdoc, Subtle Medical and ScreenPoint. Among them, AIdoc secured the most recent funding round in April, 2026.

Neurogram - 2026 Company Profile, Team, Funding & Competitors

Most viewed in 2019

Neurogram is a seed company based in Atlanta (United States), founded in 2021 by Daniele De Mari and Phillip Kinney. It operates as a Provider of AI-based diagnostic platform for neurological diseases. Neurogram has raised $4.4M in funding from investors like Dorm Room Fund, Caffeinated Capital and Z Fellows. The company has 779 active competitors, including 170 funded and 44 that have exited. Its top competitors include companies like AIdoc, Subtle Medical and ScreenPoint.

Key Metrics

Founded Year

2021

Location

Atlanta, United States

Stage

Seed

Total Funding

$4.4M in 2 rounds

Latest Funding Round

Seed, Jul 29, 2025, $*****

Investors

Dorm Room Fund & 6 more

Ranked

74^th among 779 active competitors

Employee Count

27 as on Mar 31, 2026

Similar Companies

ScreenPoint & 680 more

View Neurogram's full profile

Neurogram has raised a total funding of $4.4M over 2 rounds. Its first funding round was on Nov 23, 2023. Its latest funding round was a Seed round on Jul 29, 2025 for $*****. 1 investor participated in its latest round. Neurogram has 7 institutional investors.

Here is the list of recent funding rounds of Neurogram:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 29, 2025	5222364	Seed	3943242	5381908	6077636	4842272
Nov 23, 2023	6475345	Seed	7436868	5121123	Starship Ventures & 5 more	5567861

Access funding benchmarks and valuations. Sign up today!

View details of Neurogram's funding rounds and investors

The founders of Neurogram are Daniele De Mari and Phillip Kinney. Daniele De Mari is the CEO of Neurogram.

Here are the details of Neurogram's key team members:

Daniele De Mari: Co-Founder & CEO of Neurogram.
Contact Info: 1 email address
Phillip Kinney: Technical Founder of Neurogram.

View details of Neurogram's Founder profiles and Board Members

Neurogram's employee count trend

Neurogram has 27 employees as of Mar 26. Here is Neurogram's employee count trend over the years:

Uncover Neurogram's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neurogram include AIdoc, Subtle Medical and ScreenPoint. Here is the list of Top 10 competitors of Neurogram, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$534M	AIC, General Catalyst & 35 others	69/100
2nd	Subtle Medical 2017, Palo Alto (United States), Series B	AI-driven solutions for medical diagnostic imaging	$50M	3E Bioventures Capital, Bessemer Venture Partners ... & 23 others	65/100
3rd	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Provider of AI-based medical image analysis systems	$47M	Insight Partners, Siemens & 3 others	63/100
4th	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of AI-powered medical imaging software for disease assessment and treatment	$63.3M	Parkwalk, IP Group Hostplus Innovation Fund ... & 16 others	63/100
5th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	Fidelity Investments, T. Rowe Price & 20 others	63/100
6th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Khosla Ventures, Open Field Capital & 12 others	63/100
7th	IXICO 2004, London (United Kingdom), Public	AI-based medical image management and analysis solutions for healthcare organizations	-	Leonne International, Gov & 3 others	62/100
8th	AI Medical Service 2017, Toshima City (Japan), Series C	AI-powered endoscopic software to detect early-stage gastrointestinal cancers	$122M	SoftBank Vision Fund, Incubate Fund & 10 others	62/100
9th	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	SBI Investment Korea, ES Investor & 18 others	61/100
10th	See-Mode Technologies 2017, Singapore (Singapore), Acquired	Provider of AI-based platform for stroke prediction	$8M	Blackbird Ventures, MassMutual Ventures & 11 others	61/100
74th	Neurogram 2021, Atlanta (United States), Seed	Provider of AI-based diagnostic platform for neurological diseases	$4.4M	Dorm Room Fund, Caffeinated Capital & 5 others	45/100